Ying-Bo Chen

819 total citations
33 papers, 429 citations indexed

About

Ying-Bo Chen is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Ying-Bo Chen has authored 33 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 15 papers in Gastroenterology and 11 papers in Surgery. Recurrent topics in Ying-Bo Chen's work include Gastric Cancer Management and Outcomes (22 papers), Metastasis and carcinoma case studies (17 papers) and Gastrointestinal Tumor Research and Treatment (15 papers). Ying-Bo Chen is often cited by papers focused on Gastric Cancer Management and Outcomes (22 papers), Metastasis and carcinoma case studies (17 papers) and Gastrointestinal Tumor Research and Treatment (15 papers). Ying-Bo Chen collaborates with scholars based in China, Hong Kong and United States. Ying-Bo Chen's co-authors include Run‐Cong Nie, Shuqiang Yuan, Yuanfang Li, Xiao‐Jiang Chen, Shi Chen, Yongming Chen, Zhiwei Zhou, Junsheng Peng, Zhi-Wei Zhou and Xiaowei Sun and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ying-Bo Chen

33 papers receiving 427 citations

Peers

Ying-Bo Chen

PRM

SURGE

ONCOL

GASTR

Baojun Huang China

Toshihiro Nakao Japan

Min-Gew Choi South Korea

Bochao Zhao China

Maria Maddalena Laterza Italy

Antoine Drouillard France

Eri Munekage Japan

Soichi Tomimatsu Japan

Leo Taniguchi Japan

Luigi Sandonato Italy

Baojun Huang China

Ying-Bo Chen

297 ×1.0

PRM

250 ×1.7

SURGE

78 ×0.6

ONCOL

120 ×1.0

GASTR

77 ×1.7

Citations per year, relative to Ying-Bo Chen Ying-Bo Chen (= 1×) peers Baojun Huang

Countries citing papers authored by Ying-Bo Chen

Since Specialization

Citations

This map shows the geographic impact of Ying-Bo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying-Bo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying-Bo Chen more than expected).

Fields of papers citing papers by Ying-Bo Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying-Bo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying-Bo Chen. The network helps show where Ying-Bo Chen may publish in the future.

Co-authorship network of co-authors of Ying-Bo Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ying-Bo Chen. A scholar is included among the top collaborators of Ying-Bo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying-Bo Chen. Ying-Bo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Feiyang, et al.. (2024). First-line immune checkpoint inhibitors in low programmed death-ligand 1-expressing population. Frontiers in Pharmacology. 15. 1377690–1377690. 3 indexed citations

Li, Yuanfang, Shuqiang Yuan, Ying-Bo Chen, et al.. (2023). Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials. JNCI Journal of the National Cancer Institute. 115(9). 1085–1091. 7 indexed citations

Zhou, Jie, Run‐Cong Nie, Yixin Yin, et al.. (2022). Genomic Analysis Uncovers the Prognostic and Immunogenetic Feature of Pyroptosis in Gastric Carcinoma: Indication for Immunotherapy. Frontiers in Cell and Developmental Biology. 10. 906759–906759. 7 indexed citations

Luo, Tianqi, Guoming Chen, Run‐Cong Nie, & Ying-Bo Chen. (2022). ASO Author Reflections: The Role of Adjuvant Chemotherapy in Adenocarcinoma of the Esophagogastric Junction. Annals of Surgical Oncology. 30(7). 4026–4027. 1 indexed citations

Deng, Zijian, Jun Lü, Run‐Cong Nie, et al.. (2022). Indications for Adjuvant Chemotherapy in Stage II Gastric Cancer After D2 Gastrectomy–A Chinese Multicenter Study. Annals of Surgical Oncology. 29(13). 8214–8224. 4 indexed citations

Deng, Zijian, Run‐Cong Nie, Jun Lü, et al.. (2021). Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research. BMC Gastroenterology. 21(1). 363–363. 2 indexed citations

Wei, Xiaoli, Tianqi Luo, Jianing Li, et al.. (2021). Development and Validation of a Prognostic Classifier Based on Lipid Metabolism–Related Genes in Gastric Cancer. Frontiers in Molecular Biosciences. 8. 691143–691143. 22 indexed citations

Chen, Yonghe, Jun Lü, Run‐Cong Nie, et al.. (2021). Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients. Frontiers in Oncology. 11. 593470–593470. 10 indexed citations

Wang, Huashe, Shi Chen, Jun Xiang, et al.. (2020). Functional jejunal interposition versus Roux-en-Y anastomosis after total gastrectomy for gastric cancer: A prospective randomized clinical trial. Surgical Oncology. 34. 236–244. 4 indexed citations

10.

Nie, Run‐Cong, Shuqiang Yuan, Ying-Bo Chen, et al.. (2020). Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials. BMC Cancer. 20(1). 421–421. 14 indexed citations

11.

Chen, Guoming, Run‐Cong Nie, & Ying-Bo Chen. (2020). ASO Author Reflection: Tending Towards a Personalized Treatment for Advanced Gastric Cancer Patients by Adding the Conversion Surgery. Annals of Surgical Oncology. 27(11). 4261–4262. 1 indexed citations

12.

Chen, Guoming, Shuqiang Yuan, Run‐Cong Nie, et al.. (2020). Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer. Annals of Surgical Oncology. 27(11). 4250–4260. 16 indexed citations

13.

Yuan, Shuqiang, Run‐Cong Nie, Shuman Li, et al.. (2019). Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection. Journal of Cancer. 10(5). 1181–1188. 24 indexed citations

14.

Nie, Run‐Cong, Shuqiang Yuan, Yuanfang Li, et al.. (2019). Risk-stratification model to select conversion surgery for advanced gastric cancer patients. Chinese Journal of Cancer Research. 31(1). 178–187. 7 indexed citations

15.

Chen, Shi, Xijie Chen, Run‐Cong Nie, et al.. (2018). A nomogram to predict prognosis for gastric cancer with peritoneal dissemination. Chinese Journal of Cancer Research. 30(4). 449–459. 13 indexed citations

16.

Li, Yuanfang, Run‐Cong Nie, Ting Wu, et al.. (2018). Prognostic Value of the Nutritional Risk Screening 2002 Scale in Metastatic Gastric Cancer: A Large-Scale Cohort Study. Journal of Cancer. 10(1). 112–119. 25 indexed citations

17.

Nie, Run‐Cong, Shuqiang Yuan, Xiao‐Jiang Chen, et al.. (2017). Endoscopic ultrasonography compared with multidetector computed tomography for the preoperative staging of gastric cancer: a meta-analysis. World Journal of Surgical Oncology. 15(1). 113–113. 36 indexed citations

18.

Yuan, Shuqiang, Run‐Cong Nie, Shi Chen, et al.. (2017). Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis. Journal of Cancer. 8(12). 2231–2237. 14 indexed citations

19.

Xu, Pengfei, Haibo Qiu, Dazhi Xu, et al.. (2016). Preoperative Nutritional Deficiency Is a Useful Predictor of Postoperative Outcome in Patients Undergoing Curative Resection for Gastric Cancer. Translational Oncology. 9(6). 482–488. 10 indexed citations

20.

Nie, Run‐Cong, Shi Chen, Shuqiang Yuan, et al.. (2016). Significant Role of Palliative Gastrectomy in Selective Gastric Cancer Patients with Peritoneal Dissemination: A Propensity Score Matching Analysis. Annals of Surgical Oncology. 23(12). 3956–3963. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact